Xuanqi Xu

Xuanqi Xu

Auto-generated profile, based on publicly available information

Xuanqi Xu

Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53715, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2017 in Molecules
Verified
Journal Article
Open access
PDF file
WXWang Xinran
Wang Xinran
XLXuehua Lin
Xuehua Lin
XXXuanqi Xu
Xuanqi Xu
WLWei Li
Wei Li
LHLijuan Hao
Lijuan Hao
MCMao-Sheng Cheng
Mao-Sheng Cheng
Cholesteryl ester transfer protein (CETP) has been identified as a potential target for cardiovascular disease (CVD) for its important role in the reverse cholesteryl transfer (RCT) process. In our previous work, compound 5 was discovered as a moderate CETP inhibitor. The replacement of the amide linker by heterocyclic aromatics and then a series of N,N-substituted-4-arylthiazole-2-methylamine derivatives were designed by utilizing a conformational restriction strategy. Thirty-six compounds were synthesized and evaluated for their CETP inhibitory activities. Structure-activity relationship studies indicate that electron donor groups substituted ring A, and electron-withdrawing groups at the 4-position of ring B were critical for potency. Among these compounds, compound 30 exhibited excellent CETP inhibitory activity (IC50 = 0.79 ± 0.02 μM) in vitro and showed an acceptable metabolic stability.

3 October 2017 in Molecules
Verified
Journal Article
Open access
PDF file
WXWang Xinran
Wang Xinran
LHLijuan Hao
Lijuan Hao
XXXuanqi Xu
Xuanqi Xu
WLWei Li
Wei Li
CLChunchi Liu
Chunchi Liu
MCMao-Sheng Cheng
Mao-Sheng Cheng
N,N-Substituted amine derivatives were designed by utilizing a bioisosterism strategy. Consequently, twenty-two compounds were synthesized and evaluated for their inhibitory activity against CETP. Structure-activity relationship (SAR) studies indicate that hydrophilic groups at the 2-position of the tetrazole and 3,5-bistrifluoromethyl groups on the benzene ring provide important contributions to the potency. Among these compounds, compound 17 exhibited excellent CETP inhibitory activity (IC50 = 0.38 ± 0.08 μM) in vitro. Furthermore, compound 17 was selected for an in vitro metabolic stability study.